|
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Virgin Wines UK PLC - Norwich, England-based online wine retailer - Virgin Wines hails a ‘strong Christmas trading period’. In the seven weeks to December 26, revenue climbs 5% on-year. It notes a ‘40% increase in customers acquired and the customer base returning to growth’. For the half-year to January 2, revenue edges up 1.8% to £34.7 million from £34.1 million, ‘significantly outperforming the wider online drinks market which declined by 11%’. ‘The board is encouraged by the progress made against the four key pillars of the growth strategy and remains confident that the FY26 outturn will be in line with current market expectations,’ Virgin Wines says. ---------- Everyman Media Group PLC - London-based premium cinema chain - Everyman reports an increase in revenue and profit for year just gone, hailing ‘resilience’ in the face of tough market conditions. Revenue in the year to January 1 rises 8.7% to £116.5 million from £107.2 million. The prior financial year was 53 weeks long. On a comparable 52-week basis, revenue in that year amounted to £103.8 million. Admissions amounted to 4.4 million, up from 4.3 million. Everyman’s market share edged up to 5.8% from 5.4%. ‘The group continued to make progress in FY25, delivering growth in revenue, Ebitda and market share, supported by increased admissions and higher spend per head,’ Interim Chief Executive Officer Farah Golant commented. Last month, Alex Scrimgeour stepped down as CEO. ---------- Roebuck Food Group PLC - Dublin-based firm with divisions provided food sourcing and distribution services, ingredients and agricultural solutions - Roebuck says its GlasPort Bio unit has made ‘significant progress’ since it was acquired in February of last year. However, in Moorhead & McGavin/Foro Food Solutions, the plant-based ingredients division that supplies food services and manufacturing, had a ‘difficult’ 2025. ‘The UK Food Service market was particularly difficult,’ Roebuck adds. It notes, actions taken to keep a lid on costs does set the division up for ‘sales growth and profit recovery in 2026,’ however. ---------- MicroSalt PLC - London-based provider of low-sodium salt products - MicroSalt enters into a joint development deal with a partner, which it describes as ‘one of the world’s largest food, soft drink and snack manufacturers’. The duo will develop offering that ‘significantly reduce sodium content’ but still have ‘salty and savoury taste experiences for consumers’. The deal is ‘an important milestone for MicroSalt’, it adds, as it offers ‘increased visibility over future development activity’. ---------- Novacyt SA - biotechnology group focused on clinical diagnostics - The Yourgene Health UK unit wins a South West London Procurement Partnership tender. It is for the provision of non-invasive prenatal testing services for the St George’s University Hospitals NHS Foundation Trust, London. ‘The contract is for an initial two-year period from December 2025, with an option to extend for a further two years. This represents a continuation of existing business to the company,’ the company says. ---------- EKF Diagnostics Holdings PLC - Cardiff-headquartered medical diagnostics company - EKF expects to report 2025 revenue growth of 3% to £51.6 million from £50.2 million. The gross margin stood at 51% for the period, improving from 48%. Adjusted earnings before interest, tax, depreciation, and amortisation are expected to increase around 10% to £12.4 million from £11.3 million, in line with consensus. ---------- Ondine Biomedical Inc - British Columbia, Canada-based life sciences company - The Cowichan District Hospital in British Columbia is adopting the Steriwave nasal photodisinfection offering in pre-surgical protocols. ‘Cowichan is migrating from community hospital to a regional leader in innovation and we are proud to be part of that evolution. As this facility triples in size to become one of the most significant medical centers in British Columbia, the clinical team is ensuring that patient safety keeps pace with that growth. We are honoured to support the Cowichan Valley in helping to protect patients and families from the growing threat of drug-resistant infections with our rapid and painless photodisinfection procedure,’ CEO Carolyn Cross says. ---------- Eco Buildings Group PLC - London-based designer, manufacturer and builder of modular housing - All groundworks have been completed for a luxury 18-unit apartment development in Albania. Construction of the ground floor is now underway. ‘The company expects to make rapid progress now that construction is underway. ’We anticipate this is the first of six apartment blocks of the same size which in themselves are a precursor to a larger villa development at the same site in Albania. This construction project is undertaken for a large development group in Albania,‘ Eco Buildings adds. ---------- Northcoders Group PLC - Manchester-based software coding training provider - ’Structural changes to the UK government’s skills funding system‘ made 2025 a tough year for Northcoders, it explains. ’These shifts led to a significant drop in the number of funded learners across the entire sector. In response, the board focused on safeguarding the core of the business by maintaining disciplined cost controls, ensuring operational resilience, and prioritising higher-quality delivery, particularly in the B2B consultancy division,‘ Northcoders adds. Revenue of £5.0 million is expected for 2025, falling from £8.8 million. It says: ’Despite a significant drop in funded learners, the group kept strong gross margins thanks to disciplined delivery, careful direct cost management, and a deliberate move away from a volume based funding approach that was adopted in some areas of the training sector.‘ It expects a statutory loss for 2025, ’mainly due to the effects of changes in government funding and impairment of assets no longer crucial in current delivery‘. In 2024, it achieved pretax profit of £388,864. Looking ahead, it says: ’The board expects an improved first-half trading period relative to FY2025. Given that external market conditions concerning government-funded skills programmes will remain uncertain in the short term, we continue to adopt a cautious and disciplined approach to forecasting, ensuring that robust and prudent cash management remains a priority.‘ ---------- 88 Energy Ltd - oil exploration in Namibia and US state of Alaska - 88 gets access to the Schrader Bluff 3D seismic dataset, released by the Alaska Department of Natural Resources. The data will incorporated into its own internal exploration database. It will help ’optimise and support investment for the drilling programme‘, currently scheduled for the first quarter of 2027. ---------- Switch Metals PLC - mining exploration company focused on developing battery and technology metals mines in Ivory Coast - The washing of samples taken at the Issia project, in view of a mineral resource estimate, ’continues at pace‘. About 40% of first samples have been processed. The estimate remains on track for the first quarter of this year. Issia is a tantalum project in Ivory Coast. ---------- Bradda Head Lithium Ltd - North American-focused lithium explorer and owner of the Basin project in Arizona - Bradda enters into a joint-venture with Kennecott Exploration Inc, part of Rio Tinto PLC. The JV allows Bradda to earn-in to some licences in Arizona, labelled the Whistlejacket project. It can acquire up 60% of Whistlejacket. Bradda adds: ’The board of Bradda Head believes the project represents a compelling opportunity to expand its hard rock lithium project portfolio in Arizona, USA which currently includes its nearby existing San Domingo project and to continue exploration drilling that could lead to an economic lithium spodumene resource in one of the best jurisdictions in the world for mining projects.‘ The earn-in will be split in two phases, the first, allowing for a 51% stake is followed by a second for an additional 9%. There are ’project milestones and expenditure requirements incentivizing development of the asset‘, Bradda adds. ’At the end of each phase of the earn-in, KEX will have an option to reacquire the interests in the project earned by the company at a multiple of the expenditures made by the company, and if such option is not exercised, the company shall have the option to acquire all remaining interests in the project held by the KEX.‘ ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
